ATMI Adds New Single-Use Fill/Finish Tech in Deal with CMO D-Lab
ATMI has started selling a new cGMP-compliant fill finish platform in a continuation of its focus on what it says is the growing single-use tech market.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs